查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1226695

顯影劑注射套組的全球市場:現狀分析與預測(2022年～2028年)

Contrast Media Injection Sets Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球顯影劑注射套組的市場規模，預計2022年～2028年之間記錄約5％的年複合成長率。癌症的盛行率增加和診斷方法增加，以及，心臟，肺，骨，腦等各種疾病診斷中使用核子醫學攝影檢驗，成為市場成長的原動力。可是，注射套組的高成本和受訓練的專家不足等，妨礙在全球這個市場的成長。

本報告提供全球顯影劑注射套組市場相關調查分析，市場概要，各市場區隔、各地區的市場分析，市場成長的影響因素，市場趨勢，競爭情形，主要企業簡介等彙整資訊。

目錄

第1章 市場簡介

第2章 調查手法與前提

第3章 市場概要

第4章 摘要整理

第5章 COVID-19對顯影劑注射套組市場的影響

第6章 全球顯影劑注射套組的市場收益(2020年～2028年)

第7章 市場洞察:各產品

  • Bore Vented Tubing顯影劑注射套組
  • Vented Bifurcated Standard Bore顯影劑注射套組
  • Contrast Media Injection Sets顯影劑注射套組
  • 其他

第8章 市場洞察:各終端用戶

  • 醫院
  • 癌症調查
  • 影像診斷中心
  • 其他

第9章 市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他北美
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他亞太地區
  • 全球其他地區

第10章 顯影劑注射套組市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第11章 顯影劑注射套組市場機會

第12章 顯影劑注射套組市場趨勢洞察

第13章 需求與供給分析

  • 需求分析
  • 供給分析

第14章 價值鏈分析

第15章 價格分析

第16章 策略性洞察能力

第17章 競爭模式

  • 競爭情形
    • 波特的五力分析

第18章 公司概要

  • Bayer AG
  • ulrich GmbH & Co. KG
  • Medtron AG
  • ICU Medical, Inc
  • B. Braun SE
  • Apollo Rt Co. Ltd
  • Nemoto Kyorindo Co. Ltd
  • Guerbet Group
  • GE Healthcare
  • Shenzhen Anke High-tech Co. Ltd

第19章 免責聲明

簡介目錄
Product Code: UMME211581

The contrast media injection sets market is expected to register a CAGR of approx. 5% over the period of 2022-2028. Contrast media administration sets, or injection sets are made to regulate the number of contrast agents that are actually supplied to an administration system (such as an injector) in order to prevent waste and regulate the total amount of contrast agents used for a single procedure. When performing various imaging tests like computed tomography (CT), magnetic resonance imaging (MRI), radiography, and occasionally ultrasound imaging, contrast media are used to increase the contrast of bodily fluids for better imaging. With the aid of contrast media, blood vessels can be seen, allowing for the examination of the spine, kidneys, and internal organs of the brain. Contrast media aids in the differentiation of different body parts with similar compositions, and thus, contrast media. The growing demand for contrast media injection sets can be attributed to the increasing prevalence of cancer across the globe. For instance, according to the World Health Organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Owing to the glaring statistics the rising prevalence of cancer leads to higher demand for contrast media injection which boosts the demand for contrast media injection sets across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the contrast media injection sets market is anticipated to grow on account of the increasing number of diagnostic procedures. In addition, increasing usage of nuclear imaging tests for the diagnosis of various conditions related to the heart, lungs, bones, brain, and other systems drives the market growth. However, some of the restraints in the market including the high cost of injection sets and lack of trained professionals are impeding the growth of this market all over the world.

Based on the product, the contrast media injection sets market is segmented into contrast media injection sets with a bore vented tubing, contrast media injection sets with a vented bifurcated standard bore, contrast media injection sets with a vented pressurized spike, and others. The contrast media injection sets with a bore vented tubing segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. Professionals frequently use these products because they are simple to use and more widely available than other product categories.

Based on the end-user, the market is fragmented into hospitals, cancer research institutes, diagnostic imaging centers, and others. The diagnostic imaging centers segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Increased procedure volume, combined with patient convenience, and a lack of imaging modalities in small and medium-sized hospitals are boosting segment growth. In order to improve ease of use and create products that can help control the waste of contrast agents, manufacturers of contrast media injection sets are concentrating on creating more innovative sets.

For a better understanding of the market adoption of the contrast media injection sets, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the contrast media injection sets industry owing to increased nuclear imaging procedures and the availability of high-end products. Moreover, the presence of well-established healthcare facilities, growing advanced technologies, as well as rising healthcare spending boost the market growth in this region.

Some of the major players operating in Bayer AG; ulrich GmbH & Co. KG; Medtron AG; ICU Medical, Inc; B. Braun SE; Apollo Rt Co. Ltd; Nemoto Kyorindo Co. Ltd; Guerbet Group; GE Healthcare; Shenzhen Anke High-tech Co. Ltd among others. Several M&A's along with partnerships have been undertaken.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Contrast Media Injection Sets Market
  • 2.2. Research Methodology of the Contrast Media Injection Sets Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CONTRAST MEDIA INJECTION SETS MARKET

6 GLOBAL CONTRAST MEDIA INJECTION SETS MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

  • 7.1. Contrast Media Injection Sets with a Bore Vented Tubing
  • 7.2. Contrast Media Injection Sets with a Vented Bifurcated Standard Bore
  • 7.3. Contrast Media Injection Sets with a Vented Pressurized Spike
  • 7.4. Others

8 MARKET INSIGHTS BY END-USER

  • 8.1. Hospitals
  • 8.2. Cancer Research Institutes
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Others

9 MARKET INSIGHTS BY REGION

  • 9.1 NORTH AMERICA CONTRAST MEDIA INJECTION SETS MARKET
    • 9.1.1 U.S.
    • 9.1.2 Canada
    • 9.1.3 Rest of North America
  • 9.2 EUROPE CONTRAST MEDIA INJECTION SETS MARKET
    • 9.2.1 Germany
    • 9.2.2 France
    • 9.2.3 U.K.
    • 9.2.4 Spain
    • 9.2.5 Italy
    • 9.2.6 Rest of Europe
  • 9.3 ASIA PACIFIC CONTRAST MEDIA INJECTION SETS MARKET
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4. Australia
    • 9.3.4 Rest of Asia Pacific
  • 9.4 REST OF WORLD CONTRAST MEDIA INJECTION SETS MARKET

10 CONTRAST MEDIA INJECTION SETS MARKET DYNAMICS

  • 10.1 Market Drivers
  • 10.2 Market Challenges
  • 10.3 Impact Analysis

11 CONTRAST MEDIA INJECTION SETS MARKET OPPORTUNITIES

12 CONTRAST MEDIA INJECTION SETS MARKET TRENDS & INSIGHTS

13 DEMAND AND SUPPLY SIDE ANALYSIS

  • 13.1 Demand Side Analysis
  • 13.2 Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1 Porter's Five forces analysis

18 COMPANY PROFILED

  • 18.1. Bayer AG
  • 18.2. ulrich GmbH & Co. KG
  • 18.3. Medtron AG
  • 18.4. ICU Medical, Inc
  • 18.5. B. Braun SE
  • 18.6. Apollo Rt Co. Ltd
  • 18.7. Nemoto Kyorindo Co. Ltd
  • 18.8. Guerbet Group
  • 18.9. GE Healthcare
  • 18.10. Shenzhen Anke High-tech Co. Ltd

19 DISCLAIMER